INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL

RIBER reported that as of September 30, 2026, it had 21,253,024 shares and 21,253,024 gross voting rights; net voting rights were 21,023,804 after excluding shares without voting rights held in treasury. The monthly disclosure is factual and provides no earnings, outlook, or market reaction.

Analysis

This is a governance denominator disclosure, not evidence of a change in operating momentum or a financing event. The gap between gross and net voting rights reflects shares without voting rights, but a single month-end snapshot cannot establish whether treasury holdings changed or why. It therefore offers little standalone information about dilution, buybacks, or control; the useful signal is only in comparison with prior notices and subsequent capital actions.

For ALRIB, the more material valuation question remains whether its technology positioning converts into customer qualifications, repeat equipment orders, and service revenue. Company descriptions of growth markets and a new platform are not substitutes for independently verifiable bookings or cash conversion. No immediate catalyst or directional signal is established here. Over 1–3 months, monitor monthly share/vote disclosures alongside order intake, backlog, and cash data; over 6–18 months, commercial adoption and production-scale qualification would matter more than the voting-rights count. The thesis would change if repeated disclosures show meaningful share-count movements or if audited filings tie treasury-share activity to a capital action.

Key Decisions for Investors

• No trade on this notice alone; do not treat the voting-rights snapshot as evidence of either dilution or a buyback without comparison to prior monthly disclosures.
• For existing ALRIB exposure, check the next monthly notice and the next results for share-count changes, treasury-share movements, order intake, backlog, and cash conversion before adding risk.
• Keep ROSIE adoption as a watch item rather than a revenue assumption: seek disclosed customer qualification, production deployment, or order evidence before underwriting a structural growth premium.